Oral Anticoagulation for Atrial Fibrillation After TAVR: Is Vitamin K Antagonist Still the Primary Option?
作者信息
Van Belle Eric, Delhaye Cedric, Vincent Flavien
机构信息
Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, CHU Lille, Institut Cœur Poumon, Cardiology, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille, France.
出版信息
JACC Adv. 2023 Mar 31;2(2):100278. doi: 10.1016/j.jacadv.2023.100278. eCollection 2023 Mar.
Abstract
摘要
Zotero 插件